USANA Health Sciences, Inc. (USNA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for USANA Health Sciences, Inc., with annual and quarterly history.
| Metric | 2026 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 33.56x | 16.19x | 16.18x | 14.77x | 17.50x | 13.01x |
| P/B Ratio | 0.68x | 1.28x | 2.08x | 2.36x | 5.16x | 3.67x |
| P/S Ratio | 0.39x | 0.80x | 1.12x | 1.03x | 1.72x | 1.43x |
| Profitability | ||||||
| Gross Margin | 78.3% | 79.4% | 79.4% | 79.2% | 80.5% | 80.4% |
| Operating Margin | 5.5% | 7.8% | 10.1% | 10.8% | 14.3% | 15.6% |
| Net Margin | 1.2% | 4.9% | 6.9% | 6.9% | 9.8% | 11.0% |
| EBITDA Margin | 8.9% | 11.6% | 13.4% | 13.0% | 16.3% | 17.7% |
| Liquidity | ||||||
| Current Ratio | 2.24x | 2.00x | 3.52x | 2.65x | 2.26x | 2.52x |
| Quick Ratio | 1.45x | 1.50x | 3.00x | 2.18x | 1.65x | 1.98x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.07x | 0.03x | 0.03x | 0.04x | 0.05x |
YoY = year-over-year change. Source: FMP..